Description
Artesunate Injection
• Product Overview
Artesunate Injection is a rapid-acting antimalarial medication used for the treatment of severe malaria, including malaria caused by Plasmodium falciparum. It is a water-soluble derivative of artemisinin that acts quickly by reducing parasite burden in the blood. Artesunate Injection is administered by intravenous (IV) or intramuscular (IM) injection and is recommended for use in hospitals and emergency care settings for severe malaria management.
• Available Strengths
– Artesunate 60 mg Injection
– Artesunate 120 mg Injection
• Therapeutic Category
Antimalarial Agent / Artemisinin Derivative
• Indications
Artesunate Injection is indicated for:
– Severe Malaria
– Complicated Plasmodium falciparum Malaria
– Cerebral Malaria
– Severe Malaria with Organ Dysfunction
– Malaria in Patients Unable to Take Oral Antimalarial Therapy
• Common Side Effects
Some patients may experience:
– Nausea
– Vomiting
– Dizziness
– Headache
– Injection site reactions
– Fever or chills
• Serious Side Effects
Seek immediate medical attention if any of the following occur:
– Delayed hemolytic anemia (especially after treatment of severe malaria)
– Severe allergic reactions
– Liver function abnormalities
– Low blood cell counts (rare)
• Precautions
– Use only under the supervision of a healthcare professional.
– For IV or IM administration only.
– Complete the recommended antimalarial treatment course with an appropriate follow-on therapy as advised.
– Monitor hemoglobin levels after treatment when clinically indicated.
– Use cautiously in patients with severe liver or kidney impairment.
– Store below 25°C, protected from light.
• Technical Information
• Active Ingredient
– Artesunate:
– 60 mg
– 120 mg
• Mechanism of Action
Artesunate is converted to the active metabolite dihydroartemisinin (DHA), which damages malaria parasite proteins and membranes, leading to rapid reduction of parasitemia.
• Dosage Form
Sterile Powder for Injection
• Route of Administration
Intravenous (IV) / Intramuscular (IM)
• Shelf Life
24–36 Months (depending on packaging and regulatory requirements)
• Storage Conditions
Store below 25°C in a dry place, protected from light.
• Product Specifications
Product Name:- Artesunate Injection
Generic Name:- Artesunate
Strength:- 60 mg / 120 mg
Dosage Form:- Sterile Powder for Injection
Category:- Antimalarial Agent
Packaging:- Glass Vial with Diluent / Customized Export Packing
Pack Size:- 1 Vial
Shelf Life:- 24–36 Months
Storage:- Below 25°C
Origin:- India
• Regulatory Status & Supply Information
– Manufactured in WHO-GMP compliant facilities.
– Available for international export markets.
– Export documentation support available.
– Private Label Manufacturing available.
– Third-party manufacturing available.
– Customized export packaging available.
– Bulk quantities available for distributors, hospitals, malaria control programs, government tenders, and NGOs.
• Who Should Source This Product?
– Pharmaceutical Importers
– Pharmaceutical Distributors
– Hospital Procurement Companies
– Government Health Programs
– Malaria Control Agencies
– NGO Medical Supply Organizations
– Tender Suppliers
– Private Label Brands
• Why Source From Mediora Exports?
– Trusted Pharmaceutical Exporter from India
– WHO-GMP Manufacturing Partners
– Competitive International Pricing
– Wide Pharmaceutical Product Portfolio
– Reliable Global Supply Chain
– Flexible Packaging Options
– Complete Export Documentation Support
• Contact Details
Mediora Exports
📧 info@medioraexports.com
📱 +91 99047 64844

Reviews
There are no reviews yet.